Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

44251 - 44260 of 44782 results found

New Drugs 2021, Part 2

Date
Tuesday, September 28, 2021 - 4:00 AM
Description
The second of a two-part series, this article describes eight recently approved drugs, including the first drug approved for the treatment of SARS-CoV-2, a first-in-class HIV attachment inhibitor, and a new intravenous injection indicated for the

Polyserositis secondary to COVID-19: the diagnostic dilemma

Date
Tuesday, September 28, 2021 - 4:00 AM
Description
COVID-19 is a novel disease often presenting with a cough, fever or a change in smell or taste. Recently, it has been recognised that COVID-19 may result in multisystemic issues and thus cause atypical symptoms, which can cause diagnostic delay

Virus detection via programmable Type III-A CRISPR-Cas systems

Date
Tuesday, September 28, 2021 - 4:00 AM
Description
Among the currently available virus detection assays, those based on the programmable CRISPR-Cas enzymes have the advantage of rapid reporting and high sensitivity without the requirement of thermocyclers. Type III-A CRISPR-Cas system is a multi

Spatial spillover and COVID-19 spread in the U.S

Date
Tuesday, September 28, 2021 - 4:00 AM
Description
CONCLUSION: Overall, the results indicate that high vulnerability in Minority, Epidemiological factors, Healthcare System Factors, and High-Risk Environments in each county and adjacent counties leads to an increase in COVID-19 confirmed cases.